Exploring PI3Kγ binding preference with Eganelisib, Duvelisib, and Idelalisib via energetic, pharmacophore and dissociation pathway analyses. - Lei Jia; Lingling Wang; Yingmin Jiang; Lei Xu 035; Yanfei Cai; Yun Chen; Jian Jin; Huiyong Sun; Jingyu Zhu (Comput. Biol. Medicine, 2022)